• Increasingly, pregnant patients with inflammatory or autoimmune diseases use monoclonal
antibody biologics before conception, during pregnancy and while breastfeeding.• A minority …

The development and widespread use of vaccination over the past centuries has been the
single most impactful intervention in public health, by effectively preventing morbidity and …

Within 2 years after the start of the coronavirus disease 2019 (COVID-19) pandemic, novel
severe acute respiratory syndrome coronavirus 2 vaccines were developed, rigorously …

OBJECTIVE: To summarize the literature on the risk of AEFI recurrence. DATA SOURCES:
PubMed, Embase, and Cochrane library. STUDY SELECTION: We included articles in …

Objectives Individuals and healthcare providers may be uncertain about the safety of
revaccination after an adverse event following immunization (AEFI). We identified factors …

Objectives To estimate the risk of recurrence of adverse events following immunization
(AEFIs) upon revaccination and to determine among patients with suspected vaccine allergy …

Objective Prior experience of an adverse event following immunisation is a known barrier to
vaccination. Limited Australian data evaluating adverse event recurrence among children …

Background Parents and healthcare providers usually defer or avoid immunization for
children with neurological conditions. This study was conducted to investigate the common …

Enhancing clinical management of complex adverse events following immunization (AEFIs): A
call for patient-centered solutions - ScienceDirect Skip to main contentSkip to article Elsevier …

Background A hypotonic hyporesponsive episode (HHE) is a well-described adverse event
following immunisation (AEFI) in young children. There is limited data regarding recurrence …